Soumya Chatterjee
Expertise in
34
conditions

Dr. Soumya Chatterjee

Rheumatology
2049 East 100th Street, 
Cleveland, OH 
On Staff At
Offers Telehealth
Expertise in
34
conditions
2049 East 100th Street, 
Cleveland, OH 

Overview

Soumya Chatterjee is a Rheumatologist in Cleveland, Ohio. Dr. Chatterjee is highly rated in 34 conditions, according to our data. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Scleredema, and Raynaud Phenomenon.

His clinical research consists of co-authoring 143 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency

Calcutta Medical College

Specialties

Rheumatology

Licenses

Internal Medicine in OH

Board Certifications

American Board Of Internal Medicine, 2001

Fellowships

Northern and Yorkshire Region Health Authority, United Kingdom

Hospital Affiliations

Cleveland Clinic
South Pointe Hospital
Mercy Medical Center
Akron General Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AultCare
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
CommuniCare Advantage
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Ohio Health Group
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Primetime Health Plan
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE PART D
Provider Partners Health Plan
  • MEDICARE SNP
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
SummaCare
  • HMO
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Univera Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 28 Less Insurance Carriers -

Locations

Cleveland Clinic Main Campus
2049 East 100th Street, Cleveland, OH 44106

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Drug: Iloprost
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics, and Explore Efficacy of TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis
A Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics, and Explore Efficacy of TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: June 28, 2024
Intervention Type: Biological, Other
Study Drug: Tepezza Anti-IGF-1 Receptor Monoclonal Antibody
Study Phase: Phase 1
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Enrollment Status: Completed
Publish Date: February 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

143 Total Publications

Painful Hand Swelling With Finger Contractures.
Painful Hand Swelling With Finger Contractures.
Journal: JAMA
Published: October 16, 2025
Similar Doctors
Patompong Ungprasert
Expertise in
30
conditions
Dr. Patompong Ungprasert
Rheumatology
Expertise in
30
conditions
Dr. Patompong Ungprasert
Rheumatology

Cleveland Clinic

9500 Euclid Ave, 
Cleveland, OH 
 (0.1 miles away)
216-445-4745
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Patompong Ungprasert is a Rheumatologist in Cleveland, Ohio. Dr. Ungprasert is highly rated in 30 conditions, according to our data. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Vasculitis, Endoscopy, and Sleeve Gastrectomy.

Rula Hajj
Expertise in
35
conditions
Dr. Rula Hajj
Rheumatology
Expertise in
35
conditions
Dr. Rula Hajj
Rheumatology

Cleveland Clinic Main Campus

2049 East 100th Street, 
Cleveland, OH 
 (0.3 miles away)
216-444-2200
Experience:
37+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rula Hajj is a Rheumatologist in Cleveland, Ohio. Dr. Hajj has been practicing medicine for over 37 years is highly rated in 35 conditions, according to our data. Her top areas of expertise are Vasculitis, Granulomatosis with Polyangiitis, Scleritis, and Goodpasture Syndrome.

Expertise in
29
conditions
Dr. Alexandra C. Villa-Forte
Rheumatology
Expertise in
29
conditions
Dr. Alexandra C. Villa-Forte
Rheumatology

Cleveland Clinic

9500 Euclid Ave, 
Cleveland, OH 
 (0.1 miles away)
216-444-2200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Alexandra Villa-Forte is a Rheumatologist in Cleveland, Ohio. Dr. Villa-Forte is highly rated in 29 conditions, according to our data. Her top areas of expertise are Granulomatosis with Polyangiitis, Vasculitis, Polyarteritis Nodosa, Temporal Arteritis, and Tissue Biopsy. Dr. Villa-Forte is currently accepting new patients.

Frequently Asked Questions about Dr. Soumya Chatterjee

How do I make an appointment with Dr. Soumya Chatterjee?

You can book an appointment with Dr. Soumya Chatterjee by calling their office at 216-444-2200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Soumya Chatterjee a top-rated expert for Scleroderma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Soumya Chatterjee is classified as an Elite expert for Scleroderma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Soumya Chatterjee specialize in?

While Dr. Soumya Chatterjee is a Rheumatology, they have specific expertise in Scleroderma, Systemic Sclerosis (SSc), and Scleredema. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Soumya Chatterjee participate in research or clinical trials?

Yes. Dr. Soumya Chatterjee has published 143 articles and abstracts on conditions like Scleroderma. You can view a list of Dr. Soumya Chatterjee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Soumya Chatterjee accept my insurance?

Dr. Soumya Chatterjee accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 216-444-2200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chatterjee's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 21 Advanced Conditions
View All 51 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile